Health Condition 1: 8- Other Procedures
Conditions
Interventions
Intervention1: TRANSDERMAL BUPRENORPHINE PATCH: Preoperative Preparation
A transdermal buprenorphine patch (5 g/h) is applied to the upper outer arm of the patient approximately 12 h prior to surgery
Sponsors
S Nijalingappa medical college
Eligibility
Inclusion criteria
Inclusion criteria: Female patients aged 20 50 years Undergoing major gynaecological surgery under general or regional anesthesia ASA physical status I or II Willing to give informed consent
Exclusion criteria
Exclusion criteria: Known allergy or hypersensitivity to buprenorphine, paracetamol, or diclofenac History of chronic pain or long-term opioid use Hepatic or renal dysfunction Severe cardiopulmonary illness Psychiatric illness or cognitive impairment Refusal to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| to evaluate and compare the safety and efficacy of transdermal buprenorphine patch plus paracetamol vs diclofenac injection in randomised gynaecological surgeries and the onset and duration of analgesia following major gynaecological surgeriesTimepoint: to check VAS score at 4 hours 12 hours 24 hours post op day 2 and post op day 3 | — |
Secondary
| Measure | Time frame |
|---|---|
| The duration & efficacy of post operative analgesia defined by the time interval between the end of surgery & a Visual Analogue Scale VAS pain score more than 4Timepoint: to check VAS score at 4 hours 12 hours 24 hours post op day 2 & post op day 3 | — |
Countries
India
Contacts
Public ContactDr Nandashree R V
S Nijalingappa medical college and HSK hospital and research centre, Bagalkot
Outcome results
None listed